Symptom Management Strategies for Patients Receiving Anaplastic Lymphoma Kinase Inhibitors for Non–Small Cell Lung Cancer
Jennifer Jacky, MSN, ARNP, and Christina Baik, MD, MPH
Seattle Cancer Care Alliance and Department of Medicine (Medical Oncology Division), University of Washington, Seattle, Washington; and Department of Medicine (Medical Oncology Division), University of Washington School of Medicine, Seattle, Washington
Authors’ disclosures of potential conflicts of interest are found at the end of this article.
Jennifer Jacky, MSN, ARNP, Seattle Cancer Care Alliance, Thoracic Head and Neck Medical Oncology, 825 Eastlake Avenue East, Seattle, WA 98109. E-mail: Jjacky@seattlecca.org
J Adv Pract Oncol 2017;8:729–735 |
© 2017 Harborside™
For access to the full length article, please sign in